6/21/2023 | EM | Fitch revises Hikma outlook to positive
|
10/22/2020 | EM | Fitch assigns Hikma BBB-
|
7/10/2020 | BWEM | Market Commentary: Emerging Markets: Sovereign market mostly quiet; Indonesia prices yen tranches
|
7/7/2020 | EM | New Issue: Jordan’s Hikma prices $500 million of 3¼% notes due 2025 at 98.862
|
7/1/2020 | EM | Jordan’s Hikma plans to issue benchmark dollar-denominated notes
|
6/29/2020 | EM | S&P rates Hikma notes BBB-
|
6/29/2020 | EM | Moody’s assigns Hikma notes Ba1
|
6/29/2020 | EM | S&P ups Hikma Pharmaceuticals
|
6/27/2019 | EM | S&P lifts Hikma view to positive
|
6/29/2018 | EM | S&P affirms Hikma Pharmaceuticals
|
4/8/2015 | EM | Market Commentary: Mexico sells eurobond; Turkey, Shinhan Bank do deals; Ras al-Khaimah, Petronas active
|
4/7/2015 | HYIG | Market Commentary: Pacific Rubiales in focus; roadshows for Malaysia, Formosa; Kuwait bank, Hikma trade higher
|
4/7/2015 | EM | Market Commentary: Pacific Rubiales in focus; roadshows for Malaysia, Formosa; Kuwait bank, Hikma trade higher
|
4/1/2015 | HYIG | Market Commentary: National Bank of Kuwait, Hikma sell bonds; Pacific Rubiales downgraded; Ukraine gets support
|
4/1/2015 | EM | Market Commentary: National Bank of Kuwait, Hikma sell bonds; Pacific Rubiales downgraded; Ukraine gets support
|
4/1/2015 | EM | New Issue: Jordan’s Hikma prices $500 million 4¼% notes due 2020 at 287.5 bps over mid-swaps
|
3/25/2015 | HYIG | Market Commentary: Primary sees Emirates, ColTel, Astra Sedaya, Beijing Capital deals; Hikma sets roadshow
|
3/25/2015 | EM | S&P rates Hikma notes BB+
|
3/25/2015 | EM | Moody’s assigns Hikma CFR, notes Ba1
|
3/25/2015 | EM | Jordan’s Hikma Pharmaceuticals taps banks for dollar notes roadshow
|
3/18/2015 | HYIG | Market Commentary: Slovenia sells notes; BBK notes widen; Pacific Rubiales in the news; FOMC on market’s mind
|
3/18/2015 | EM | Market Commentary: Slovenia sells notes; BBK notes widen; Pacific Rubiales in the news; FOMC on market’s mind
|
3/18/2015 | EM | Jordan’s Hikma plans to sell benchmark dollar-denominated notes
|
1/25/2006 | BT | Hikma announces FDA approval for Cephalexin, Saudi Arabia facility
|
11/30/2005 | BT | Hikma underwriters exercise greenshoe for 260,456 shares, raising sale to £149.56 million
|
11/1/2005 | BT | New Issue: Hikma prices £148.8 million IPO at 290p
|